Neurocrine Bioscience buy Needham & Company LLC
Start price
06.04.26
/
50%
€113.60
Target price
06.04.27
€160.60
Performance (%)
37.68%
Price
12:31
€156.50
Summary
This prediction is currently active. With a performance of 37.68% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 06.04.27. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 4.359% | 4.359% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $185.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
25.80%
12:31
12:31
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
10.28%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.30
15.04.25
15.04.25
€121.87
15.04.26
15.04.26
27.81%
16.04.26
16.04.26